Gwenan Mary Knight (Gwenan Knight, Gwen M Knight, Gwenan M Knight)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 36

Top Topics

Antimicrobial Resistance

Staphylococcus Aureus

Mycobacterium Tuberculosis

Top Venues

Wellcome open research

medRxiv : the preprint server for health sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Naomi M Fuller, Christopher Finn McQuaid, Martin J Harker, Chathika Krishan Weerasuriya, Timothy D McHugh, Gwenan Mary Knight
Mathematical models of drug-resistant tuberculosis lack bacterial heterogeneity: A systematic review. PLoS pathogens 20 (4) (2024)
Naomi M Fuller, Christopher Finn McQuaid, Martin J Harker, Chathika Krishan Weerasuriya, Timothy D McHugh, Gwenan Mary Knight
Mathematical models of drug-resistant tuberculosis lack bacterial heterogeneity: A systematic review. PLoS pathogens 20 (4) (2024)
Naomi R Waterlow, Ben S Cooper, Julie V Robotham, Gwenan Mary Knight
Antimicrobial resistance prevalence in bloodstream infection in 29 European countries by age and sex: An observational study. PLoS medicine 21 (3) (2024)
Naomi R Waterlow, Ben S Cooper, Julie V Robotham, Gwenan Mary Knight
Antimicrobial resistance prevalence in bloodstream infection in 29 European countries by age and sex: An observational study. PLoS medicine 21 (3) (2024)
Naomi R Waterlow, Ben S Cooper, Julie V Robotham, Gwenan Mary Knight
Antimicrobial resistance prevalence in bloodstream infection in 29 European countries by age and sex: An observational study. PLoS medicine 21 (3) (2024)
Jacob Wildfire, Naomi R Waterlow, Alastair Clements, Naomi M Fuller, Gwenan Mary Knight
MIC distribution analysis identifies differences in AMR between population sub-groups. Wellcome open research 9 (2024)
Naomi M Fuller, Christopher Finn McQuaid, Martin J Harker, Chathika Krishan Weerasuriya, Timothy D McHugh, Gwenan Mary Knight
Mathematical models of drug-resistant tuberculosis lack bacterial heterogeneity: A systematic review. PLoS pathogens 20 (4) (2024)
Naomi R Waterlow, Ben S Cooper, Julie V Robotham, Gwenan Mary Knight
Antimicrobial resistance prevalence in bloodstream infection in 29 European countries by age and sex: An observational study. PLoS medicine 21 (3) (2024)
Jacob Wildfire, Naomi R Waterlow, Alastair Clements, Naomi M Fuller, Gwenan Mary Knight
MIC distribution analysis identifies differences in AMR between population sub-groups. Wellcome open research 9 (2024)
Jacob Wildfire, Naomi R Waterlow, Alastair Clements, Naomi M Fuller, Gwenan Mary Knight
MIC distribution analysis identifies differences in AMR between population sub-groups. Wellcome open research 9 (2024)
Naomi M Fuller, Christopher Finn McQuaid, Martin J Harker, Chathika Krishan Weerasuriya, Timothy D McHugh, Gwenan Mary Knight
Mathematical models of drug-resistant tuberculosis lack bacterial heterogeneity: A systematic review. PLoS pathogens 20 (4) (2024)
Quentin J Leclerc, Alastair Clements, Helen Dunn, James Hatcher, Jodi A Lindsay, Louis Grandjean, Gwenan Mary Knight
Quantifying patient- and hospital-level antimicrobial resistance dynamics in Staphylococcus aureus from routinely collected data. medRxiv : the preprint server for health sciences (2023)
Quentin J Leclerc, Alastair Clements, Helen Dunn, James Hatcher, Jodi A Lindsay, Louis Grandjean, Gwenan Mary Knight
Quantifying patient- and hospital-level antimicrobial resistance dynamics in Staphylococcus aureus from routinely collected data. medRxiv : the preprint server for health sciences (2023)
Jay Achar, James A Seddon, Gwenan Mary Knight, Peter J Dodd, Hanif Esmail, Jennifer Hughes, Christopher Finn McQuaid
Guiding pragmatic treatment choices for rifampicin-resistant tuberculosis in the absence of second-line drug susceptibility testing. The European respiratory journal (2023)
Nicolas A Menzies, Brian W Allwood, Anna S Dean, Peter J Dodd, Rein M G J Houben, Lyndon P James, Gwenan Mary Knight, Jamilah Meghji, Linh N Nguyen, Andrea Rachow, Samuel G Schumacher, Fuad Mirzayev, Ted Cohen
Global burden of disease due to rifampicin-resistant tuberculosis: a mathematical modeling analysis. Nature communications 14 (1) (2023)
Quentin J Leclerc, Alastair Clements, Helen Dunn, James Hatcher, Jodi A Lindsay, Louis Grandjean, Gwenan Mary Knight
Quantifying patient- and hospital-level antimicrobial resistance dynamics in Staphylococcus aureus from routinely collected data. medRxiv : the preprint server for health sciences (2023)
Quentin J Leclerc, Jodi A Lindsay, Gwenan Mary Knight
Modelling the synergistic effect of bacteriophage and antibiotics on bacteria: Killers and drivers of resistance evolution. PLoS computational biology 18 (11) (2022)
Gwenan Mary Knight, Thi Mui, James Stimson, Sebastian Funk, Yalda Jafari, Diane Pople, Stephanie Evans, Mo Yin, Colin S Brown, Alex Bhattacharya, Russell Hope, Malcolm G Semple, Jonathan M Read, Ben S Cooper, Julie V Robotham
The contribution of hospital-acquired infections to the COVID-19 epidemic in England in the first half of 2020. Research square (2022)
Gwenan Mary Knight, Thi Mui Pham, James Stimson, Sebastian Funk, Yalda Jafari, Diane Pople, Stephanie Evans, Mo Yin, Colin S Brown, Alex Bhattacharya, Russell Hope, Malcolm G Semple, null null, null null, Jonathan M Read, Ben S Cooper, Julie V Robotham
The contribution of hospital-acquired infections to the COVID-19 epidemic in England in the first half of 2020. BMC infectious diseases 22 (1) (2022)
Quentin J Leclerc, Jacob Wildfire, Arya Gupta, Jodi A Lindsay, Gwenan Mary Knight
Growth-Dependent Predation and Generalized Transduction of Antimicrobial Resistance by Bacteriophage. mSystems 7 (2) (2022)
Christopher Grollman, Marina Alice Sylvia Daniele, Lia Brigante, Gwenan Mary Knight, Laura Latina, Andrei Scott Morgan, Soo Downe
Maternity service reconfigurations for intrapartum and postnatal midwifery staffing shortages: modelling of low-risk births in England. BMJ open 12 (9) (2022)
Gwenan Mary Knight, Rebecca E Glover, C Finn McQuaid, Ioana D Olaru, Karin Gallandat, Quentin J Leclerc, Naomi M Fuller, Sam J Willcocks, Rumina Hasan, Esther van Kleef, Clare I R Chandler
Antimicrobial resistance and COVID-19: Intersections and implications. eLife 10 (2021)
Akira Endo 遠藤彰, null null, Quentin J Leclerc, Gwenan Mary Knight, Graham F Medley, Katherine E Atkins, Sebastian Funk, Adam J Kucharski
Implication of backward contact tracing in the presence of overdispersed transmission in COVID-19 outbreaks. Wellcome open research 5 (2021)
Rebecca Claire Harris, Tom Sumner, Gwenan Mary Knight, Hui Zhang, Richard G White
Potential impact of tuberculosis vaccines in China, South Africa, and India. Science translational medicine 12 (564) (2021)
Dina Mohamed Youssef, Barbara Wieland, Gwenan Mary Knight, Jo Lines, Nichola R Naylor
The effectiveness of biosecurity interventions in reducing the transmission of bacteria from livestock to humans at the farm level: A systematic literature review. Zoonoses and public health 68 (6) (2021)
Christopher Finn McQuaid, Ted Cohen, Anna S Dean, Rein M G J Houben, Gwenan Mary Knight, Matteo Zignol, Richard G White
Ongoing challenges to understanding multidrug- and rifampicin-resistant tuberculosis in children versus adults. The European respiratory journal 57 (2) (2021)
Quentin J Leclerc, Naomi M Fuller, Lisa E Knight, null null, Sebastian Funk, Gwenan Mary Knight
What settings have been linked to SARS-CoV-2 transmission clusters? Wellcome open research 5 (2020)
Quentin J Leclerc, Nichola R Naylor, Alexander M Aiken, Francesc Coll, Gwenan Mary Knight
Feasibility of informing syndrome-level empiric antibiotic recommendations using publicly available antibiotic resistance datasets. Wellcome open research 4 (2020)
C Finn McQuaid, Katherine C Horton, Anna S Dean, Gwenan Mary Knight, Richard G White
The risk of multidrug- or rifampicin-resistance in males versus females with tuberculosis. The European respiratory journal 56 (3) (2020)
Quentin J Leclerc, Naomi M Fuller, Lisa E Knight, null null, Sebastian Funk, Gwenan Mary Knight
What settings have been linked to SARS-CoV-2 transmission clusters? Wellcome open research (2020)
Jon C Emery, Timothy W Russell, Yang Liu, Joel Hellewell, Carl Ab Pearson, null null, Gwenan Mary Knight, Rosalind M Eggo, Adam J Kucharski, Sebastian Funk, Stefan Flasche, Rein M G J Houben
The contribution of asymptomatic SARS-CoV-2 infections to transmission on the Diamond Princess cruise ship. eLife 9 (2020)
Gwenan Mary Knight, Mirko Zimic, Sebastian Funk, Robert H Gilman, Jon S Friedland, Louis Grandjean
The relative fitness of drug-resistant Mycobacterium tuberculosis: a modelling study of household transmission in Peru. Journal of the Royal Society, Interface 15 (143) (2019)
Gwenan Mary Knight, Nicholas G Davies, Caroline Colijn, Francesc Coll, Tjibbe Donker, Danna R Gifford, Rebecca E Glover, Mark Jit, Elizabeth Klemm, Sonja Lehtinen, Jodi A Lindsay, Marc Lipsitch, Martin J Llewelyn, Ana L P Mateus, Julie V Robotham, Mike Sharland, Dov Stekel, Laith Yakob, Katherine E Atkins
Mathematical modelling for antibiotic resistance control policy: do we know enough? BMC infectious diseases 19 (1) (2019)
Quentin J Leclerc, Nichola R Naylor, Alexander M Aiken, Francesc Coll, Gwenan Mary Knight
Feasibility of informing syndrome-level empiric antibiotic recommendations using publicly available antibiotic resistance datasets. Wellcome open research (2019)
Gwenan Mary Knight, Céire Costelloe, Sarah R Deeny, Luke S P Moore, Susan Hopkins, Alan P Johnson, Julie V Robotham, Alison H Holmes
Quantifying where human acquisition of antibiotic resistance occurs: a mathematical modelling study. BMC medicine 16 (1) (2018)
Gwenan Mary Knight, Eleonora Dyakova, Siddharth Mookerjee, Frances Davies, Eimear T Brannigan, Jonathan A Otter, Alison H Holmes
Fast and expensive (PCR) or cheap and slow (culture)? A mathematical modelling study to explore screening for carbapenem resistance in UK hospitals. BMC medicine 16 (1) (2018)